Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Puretech Health Plc (PRTC.LN)

Puretech Health Plc (PRTC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 300,717
  • Shares Outstanding, K 240,189
  • Annual Sales, $ 4,315 K
  • Annual Income, $ 53,510 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 98.31
  • Price/Cash Flow N/A
  • Price/Book 0.96
  • Price/Earnings ttm 7.89
  • Earnings Per Share ttm 0.21
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
118.000 +4.41%
on 04/14/25
134.000 -8.06%
on 04/23/25
+5.200 (+4.41%)
since 04/11/25
3-Month
100.400 +22.71%
on 04/09/25
149.000 -17.32%
on 02/18/25
-21.400 (-14.80%)
since 02/12/25
52-Week
100.400 +22.71%
on 04/09/25
238.500 -48.34%
on 06/05/24
-98.800 (-44.50%)
since 05/10/24
Free Barchart Webinars! Live educational sessions using site features to explore today's markets.

Most Recent Stories

More News
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic Business Wire - Thu May 4, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted today that its Founded Entity, Akili, Inc. (Nasdaq: AKLI) (“Akili”),...

PRTC.LN : 123.200 (-1.60%)
PRTC : 16.78 (-2.72%)
AKLI : 0.4320 (-0.62%)
PureTech Announces Annual Results for Year Ended December 31, 2022 Business Wire - Fri Apr 28, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”) today announces its results for the year ended December 31, 2022, as well as its cash balance as of the first quarter...

PRTC.LN : 123.200 (-1.60%)
PRTC : 16.78 (-2.72%)
KRTX : 329.83 (+0.03%)
VOR : 0.1513 (-5.44%)
AKLI : 0.4320 (-0.62%)
BIIB : 118.17 (-0.19%)
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies Business Wire - Tue Apr 25, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Vedanta Biosciences , a clinical-stage...

PRTC.LN : 123.200 (-1.60%)
PRTC : 16.78 (-2.72%)
PureTech Founded Entity Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMID Business Wire - Mon Apr 17, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Vedanta Biosciences, a clinical-stage...

PRTC.LN : 123.200 (-1.60%)
PRTC : 16.78 (-2.72%)
PureTech Health: Notice of Results Business Wire - Thu Apr 13, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its annual report and financial results on Friday, April 28, 2023, at 2:00 AM EDT/ 7:00 AM BST. The report...

PRTC.LN : 123.200 (-1.60%)
PRTC : 16.78 (-2.72%)
PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million Business Wire - Thu Mar 23, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, and Royalty...

PRTC.LN : 123.200 (-1.60%)
RPRX : 33.15 (+0.15%)
PRTC : 16.78 (-2.72%)
PureTech to Present at the Barclays Global Healthcare Conference Business Wire - Wed Mar 1, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced...

PRTC.LN : 123.200 (-1.60%)
PRTC : 16.78 (-2.72%)
PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD) Business Wire - Mon Feb 27, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Sonde Health , a health technology...

PRTC.LN : 123.200 (-1.60%)
PRTC : 16.78 (-2.72%)
PureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum Depression Business Wire - Tue Feb 14, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced...

PRTC.LN : 123.200 (-1.60%)
PRTC : 16.78 (-2.72%)
PureTech to Present at the SVB Securities Global Biopharma Conference Business Wire - Wed Feb 1, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced...

PRTC.LN : 123.200 (-1.60%)
PRTC : 16.78 (-2.72%)
More news for this symbol

Barchart Technical Opinion

Strong sell

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 129.333
2nd Resistance Point 127.467
1st Resistance Point 126.333
Last Price 123.200
1st Support Level 123.333
2nd Support Level 121.467
3rd Support Level 120.333

See More

52-Week High 238.500
Fibonacci 61.8% 185.746
Fibonacci 50% 169.450
Fibonacci 38.2% 153.154
Last Price 123.200
52-Week Low 100.400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot